Benjamin Ascher, Berthold-Josef Rzany, Philippe Kestemont, Alessio Redaelli, Benoit Hendrickx, Ivano Iozzo, Christoph Martschin, Alicia Milotich, Beatriz Molina, Hugues Cartier, Philippe Picaut, Inna Prygova
Alluzience (abobotulinumtoxinA RTU, Galderma; Lausanne, Switzerland) is the first ready to use (RTU) botulinum toxin-type A liquid solution approved for the treatment of glabellar lines in Europe. In this article, the authors provide consensus recommendations on the aesthetic usage of abobotulinumtoxinA RTU. Members of the International Board on Alluzience (IBA) convened to develop consensus on the treatment of glabellar lines as well as other facial wrinkles based on their own extensive experience. Consensus recommendations were developed to provide practical guidelines for injection of abobotulinumtoxinA RTU...
July 25, 2023: Aesthetic Surgery Journal